REPORT ID 1077

Global Aurora Kinase B Sales Market Report 2017

Publish Date
05-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the global Aurora Kinase B market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Aurora Kinase B for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Aurora Kinase B market competition by top manufacturers/players, with Aurora Kinase B sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AbbVie Inc
    Advenchen Laboratories LLC
    Aeterna Zentaris Inc
    Amgen Inc
    AstraZeneca Plc
    Chipscreen Biosciences Ltd
    Cielo Therapeutics Inc
    Sanofi
    Sareum Holdings Plc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    AZD-2811
    CS-2164
    Danusertib
    Ilorasertib
    NMI-900
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Anaplastic Large Cell Lymphoma
    Kidney Cancer
    Lung Cancer
    Prostate Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Aurora Kinase B Sales Market Report 2017
1 Aurora Kinase B Market Overview
    1.1 Product Overview and Scope of Aurora Kinase B
    1.2 Classification of Aurora Kinase B by Product Category
        1.2.1 Global Aurora Kinase B Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Aurora Kinase B Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 AZD-2811
        1.2.4 CS-2164
        1.2.5 Danusertib
        1.2.6 Ilorasertib
        1.2.7 NMI-900
        1.2.8 Others
    1.3 Global Aurora Kinase B Market by Application/End Users
        1.3.1 Global Aurora Kinase B Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Anaplastic Large Cell Lymphoma
        1.3.3 Kidney Cancer
        1.3.4 Lung Cancer
        1.3.5 Prostate Cancer
        1.3.6 Others
    1.4 Global Aurora Kinase B Market by Region
        1.4.1 Global Aurora Kinase B Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Aurora Kinase B Status and Prospect (2012-2022)
        1.4.3 China Aurora Kinase B Status and Prospect (2012-2022)
        1.4.4 Europe Aurora Kinase B Status and Prospect (2012-2022)
        1.4.5 Japan Aurora Kinase B Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Aurora Kinase B Status and Prospect (2012-2022)
        1.4.7 India Aurora Kinase B Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Aurora Kinase B (2012-2022)
        1.5.1 Global Aurora Kinase B Sales and Growth Rate (2012-2022)
        1.5.2 Global Aurora Kinase B Revenue and Growth Rate (2012-2022)

2 Global Aurora Kinase B Competition by Players/Suppliers, Type and Application
     2.1 Global Aurora Kinase B Market Competition by Players/Suppliers
        2.1.1 Global Aurora Kinase B Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Aurora Kinase B Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Aurora Kinase B (Volume and Value) by Type
        2.2.1 Global Aurora Kinase B Sales and Market Share by Type (2012-2017)
        2.2.2 Global Aurora Kinase B Revenue and Market Share by Type (2012-2017)
    2.3 Global Aurora Kinase B (Volume and Value) by Region
        2.3.1 Global Aurora Kinase B Sales and Market Share by Region (2012-2017)
        2.3.2 Global Aurora Kinase B Revenue and Market Share by Region (2012-2017)
    2.4 Global Aurora Kinase B (Volume) by Application

3 United States Aurora Kinase B (Volume, Value and Sales Price)
    3.1 United States Aurora Kinase B Sales and Value (2012-2017)
        3.1.1 United States Aurora Kinase B Sales and Growth Rate (2012-2017)
        3.1.2 United States Aurora Kinase B Revenue and Growth Rate (2012-2017)
        3.1.3 United States Aurora Kinase B Sales Price Trend (2012-2017)
    3.2 United States Aurora Kinase B Sales Volume and Market Share by Players
    3.3 United States Aurora Kinase B Sales Volume and Market Share by Type
    3.4 United States Aurora Kinase B Sales Volume and Market Share by Application

4 China Aurora Kinase B (Volume, Value and Sales Price)
    4.1 China Aurora Kinase B Sales and Value (2012-2017)
        4.1.1 China Aurora Kinase B Sales and Growth Rate (2012-2017)
        4.1.2 China Aurora Kinase B Revenue and Growth Rate (2012-2017)
        4.1.3 China Aurora Kinase B Sales Price Trend (2012-2017)
    4.2 China Aurora Kinase B Sales Volume and Market Share by Players
    4.3 China Aurora Kinase B Sales Volume and Market Share by Type
    4.4 China Aurora Kinase B Sales Volume and Market Share by Application

5 Europe Aurora Kinase B (Volume, Value and Sales Price)
    5.1 Europe Aurora Kinase B Sales and Value (2012-2017)
        5.1.1 Europe Aurora Kinase B Sales and Growth Rate (2012-2017)
        5.1.2 Europe Aurora Kinase B Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Aurora Kinase B Sales Price Trend (2012-2017)
    5.2 Europe Aurora Kinase B Sales Volume and Market Share by Players
    5.3 Europe Aurora Kinase B Sales Volume and Market Share by Type
    5.4 Europe Aurora Kinase B Sales Volume and Market Share by Application

6 Japan Aurora Kinase B (Volume, Value and Sales Price)
    6.1 Japan Aurora Kinase B Sales and Value (2012-2017)
        6.1.1 Japan Aurora Kinase B Sales and Growth Rate (2012-2017)
        6.1.2 Japan Aurora Kinase B Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Aurora Kinase B Sales Price Trend (2012-2017)
    6.2 Japan Aurora Kinase B Sales Volume and Market Share by Players
    6.3 Japan Aurora Kinase B Sales Volume and Market Share by Type
    6.4 Japan Aurora Kinase B Sales Volume and Market Share by Application

7 Southeast Asia Aurora Kinase B (Volume, Value and Sales Price)
    7.1 Southeast Asia Aurora Kinase B Sales and Value (2012-2017)
        7.1.1 Southeast Asia Aurora Kinase B Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Aurora Kinase B Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Aurora Kinase B Sales Price Trend (2012-2017)
    7.2 Southeast Asia Aurora Kinase B Sales Volume and Market Share by Players
    7.3 Southeast Asia Aurora Kinase B Sales Volume and Market Share by Type
    7.4 Southeast Asia Aurora Kinase B Sales Volume and Market Share by Application

8 India Aurora Kinase B (Volume, Value and Sales Price)
    8.1 India Aurora Kinase B Sales and Value (2012-2017)
        8.1.1 India Aurora Kinase B Sales and Growth Rate (2012-2017)
        8.1.2 India Aurora Kinase B Revenue and Growth Rate (2012-2017)
        8.1.3 India Aurora Kinase B Sales Price Trend (2012-2017)
    8.2 India Aurora Kinase B Sales Volume and Market Share by Players
    8.3 India Aurora Kinase B Sales Volume and Market Share by Type
    8.4 India Aurora Kinase B Sales Volume and Market Share by Application

9 Global Aurora Kinase B Players/Suppliers Profiles and Sales Data
    9.1 AbbVie Inc
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Aurora Kinase B Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Advenchen Laboratories LLC
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Aurora Kinase B Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Aeterna Zentaris Inc
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Aurora Kinase B Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Amgen Inc
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Aurora Kinase B Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 AstraZeneca Plc
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Aurora Kinase B Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Chipscreen Biosciences Ltd
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Aurora Kinase B Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Cielo Therapeutics Inc
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Aurora Kinase B Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Sanofi
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Aurora Kinase B Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Sareum Holdings Plc
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Aurora Kinase B Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview

10 Aurora Kinase B Maufacturing Cost Analysis
    10.1 Aurora Kinase B Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Aurora Kinase B
    10.3 Manufacturing Process Analysis of Aurora Kinase B

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Aurora Kinase B Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Aurora Kinase B Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Aurora Kinase B Market Forecast (2017-2022)
    14.1 Global Aurora Kinase B Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Aurora Kinase B Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Aurora Kinase B Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Aurora Kinase B Price and Trend Forecast (2017-2022)
    14.2 Global Aurora Kinase B Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Aurora Kinase B Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Aurora Kinase B Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Aurora Kinase B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Aurora Kinase B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Aurora Kinase B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Aurora Kinase B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Aurora Kinase B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Aurora Kinase B Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Aurora Kinase B Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Aurora Kinase B Sales Forecast by Type (2017-2022)
       14.3.2 Global Aurora Kinase B Revenue Forecast by Type (2017-2022)
       14.3.3 Global Aurora Kinase B Price Forecast by Type (2017-2022)
    14.4 Global Aurora Kinase B Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer